News | June 08, 2024
Briefs: Dr. Reddy's Laboratories and Ami Organics
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024
The Gold Medal distinction places the company in the top 5% of all organizations assessed within EcoVadis's rigorous framework globally
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories
Ami Organics recently announced contract with global MNC for manufacturing of electrolyte for battery cells
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
The product is expected to start contributing meaningfully to the revenue from FY25
Subscribe To Our Newsletter & Stay Updated
